Pharmaceutical Technology-Updates The latest content updates from the www.pharmaceutical-technology.com web site http://www.pharmaceutical-technology.com/ en-us http://www.pharmaceutical-technology.com/ Pharmaceutical Technology-Updates http://www.pharmaceutical-technology.com/content/images/logo_big.gif Deals this week: Affigen, Albany Molecular Research, Bristol-Myers Squibb http://www.pharmaceutical-technology.com/news/newsdeals-this-week-affigen-llc-albany-molecular-research-inc-bristol-myers-squibb-5748315 http://www.pharmaceutical-technology.com/news/newsdeals-this-week-affigen-llc-albany-molecular-research-inc-bristol-myers-squibb-5748315 In a series A venture financing round, US-based biotechnology company Affigen has raised $17m to be utilised for advancing the company’s lead programmes in a number of haematological malignancies through pre-clinical validation and into phase I clini… Fri, 24 Feb 2017 00:00:00 GMT Abivax to screen new antiviral molecules to develop therapeutic candidates against dengue fever http://www.pharmaceutical-technology.com/news/newsabivax-to-screen-new-antiviral-molecules-to-develop-therapeutic-candidates-against-dengue-5748878 http://www.pharmaceutical-technology.com/news/newsabivax-to-screen-new-antiviral-molecules-to-develop-therapeutic-candidates-against-dengue-5748878 French biotechnology company Abivax has discovered new antiviral molecules and is screening them to develop therapeutic candidates against dengue fever. Fri, 24 Feb 2017 00:00:00 GMT M&As this week: Zhejiang Conba Pharmaceutical, Biolennia Laboratories http://www.pharmaceutical-technology.com/news/newsmas-this-week-zhejiang-conba-pharmaceutical-co-ltd-biolennia-laboratories-inc-5748353 http://www.pharmaceutical-technology.com/news/newsmas-this-week-zhejiang-conba-pharmaceutical-co-ltd-biolennia-laboratories-inc-5748353 Zhejiang Conba Pharmaceutical has sold 57.3% stake in a pharmaceutical company for ¥345.1m ($50.27m). Fri, 24 Feb 2017 00:00:00 GMT Building Cure, Seattle Children’s Research Institute, Seattle http://www.pharmaceutical-technology.com/projects/building-cure-seattle-childrens-research-institute-seattle/ http://www.pharmaceutical-technology.com/projects/building-cure-seattle-childrens-research-institute-seattle/ Seattle Children's Research Institute (SCRI) is constructing a new paediatric research building named Building Cure at Stewart Street, Seattle, US. Fri, 24 Feb 2017 00:00:00 GMT US FDA awards orphan drug designation to Minoryx’s MIN-102 compound http://www.pharmaceutical-technology.com/news/newsus-fda-awards-orphan-drug-designation-to-minoryxs-min-102-compound-5748808 http://www.pharmaceutical-technology.com/news/newsus-fda-awards-orphan-drug-designation-to-minoryxs-min-102-compound-5748808 The US Food and Drug Administration (FDA) has granted orphan drug designation to Minoryx Therapeutics’ lead compound MIN-102. Fri, 24 Feb 2017 00:00:00 GMT Packaging Solutions for the Medical Device and Pharmaceutical Industry http://www.pharmaceutical-technology.com/downloads/whitepapers/packaging/packaging-solutions/ http://www.pharmaceutical-technology.com/downloads/whitepapers/packaging/packaging-solutions/ Plastiape manufactures a large range of polymers, including acrylonitrile butadiene styrene (ABS), polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), and polyoxymethylene (POM). Thu, 23 Feb 2017 16:52:00 GMT Testing Parenteral Products for Micro Leaks, Container Closure Integrity Test http://www.pharmaceutical-technology.com/downloads/whitepapers/machines-labelling/testing-parenteral-products-for-micro-leaks-container-closure-integrity-test/ http://www.pharmaceutical-technology.com/downloads/whitepapers/machines-labelling/testing-parenteral-products-for-micro-leaks-container-closure-integrity-test/ The E-Scan 655 tests container closure integrity in syringes, vials, and other liquid-filled parenteral products. Thu, 23 Feb 2017 16:51:00 GMT Efficient Synthesis Development http://www.pharmaceutical-technology.com/downloads/whitepapers/lab_equip/efficient-synthesis-development/ http://www.pharmaceutical-technology.com/downloads/whitepapers/lab_equip/efficient-synthesis-development/ It is impossible to imagine operations and development research without keywords, such as quality be design (QbD), design of experiments (DoE) or established parameter ranges (EPR). Thu, 23 Feb 2017 16:51:00 GMT Klocke uses NA and ML for Quality Storage http://www.pharmaceutical-technology.com/downloads/whitepapers/materials-handling/klocke-storage/ http://www.pharmaceutical-technology.com/downloads/whitepapers/materials-handling/klocke-storage/ The KLOCKE Group manufactures and packages pharmaceutical products, food supplements and cosmetic products. Thu, 23 Feb 2017 16:51:00 GMT Child Safe Compliance Packaging Wherever You Are in the World http://www.pharmaceutical-technology.com/downloads/whitepapers/packaging/lightweight-child-resistant-closure/ http://www.pharmaceutical-technology.com/downloads/whitepapers/packaging/lightweight-child-resistant-closure/ Origin Pharma's lightweight child-resistant closure provides an effective line of defense against child access to pharmaceuticals. Thu, 23 Feb 2017 16:50:00 GMT Helping KBI Biopharma Find a Clear Commercial Advantage http://www.pharmaceutical-technology.com/downloads/whitepapers/lab_equip/kbi-biopharma-pht/ http://www.pharmaceutical-technology.com/downloads/whitepapers/lab_equip/kbi-biopharma-pht/ Differing sample matrices and presentation can create various challenges, not least for KBI's technology platforms, which often require specialized methods and application experts in order to optimiz... Thu, 23 Feb 2017 15:00:00 GMT Valeant and EyeGate sign licensing agreement http://www.pharmaceutical-technology.com/news/newsvaleant-and-eyegate-sign-licencing-agreement-5747680 http://www.pharmaceutical-technology.com/news/newsvaleant-and-eyegate-sign-licencing-agreement-5747680 Valeant Pharmaceuticals has signed an agreement for global commercial and manufacturing rights to US-based EyeGate Pharmaceuticals’ new technology and EGP-437 combination product candidate to treat post-operative pain and inflammation in occular surg… Thu, 23 Feb 2017 00:00:00 GMT CCL Healthcare-Secondary Printed Packaging for Pharmaceuticals http://www.pharmaceutical-technology.com/contractors/machines-labelling/ccl-healthcare/ http://www.pharmaceutical-technology.com/contractors/machines-labelling/ccl-healthcare/ CCL Healthcare provides secondary printed packaging, design engineering and production services for the pharmaceutical industry. Thu, 23 Feb 2017 00:00:00 GMT Medicines Discovery Catapult: improving collaborative drug discovery in the UK http://www.pharmaceutical-technology.com/features/featuremedicines-discovery-catapult-improving-collaborative-drug-discovery-in-the-uk-5731276/ http://www.pharmaceutical-technology.com/features/featuremedicines-discovery-catapult-improving-collaborative-drug-discovery-in-the-uk-5731276/ The Medicines Discovery Catapult, one of 11 technology and innovation centres established by Innovate UK, has been set up to enable new, collaborative means of drug discovery. Abi Millar spoke to CEO Chris Molloy to find out more. Thu, 23 Feb 2017 00:00:00 GMT Northwell Health and GE Ventures collaborate to research bioelectronic medicine http://www.pharmaceutical-technology.com/news/newsnorthwell-health-ge-ventures-collaborate-to-research-on-bioelectronic-medicine-5746417 http://www.pharmaceutical-technology.com/news/newsnorthwell-health-ge-ventures-collaborate-to-research-on-bioelectronic-medicine-5746417 US-based healthcare network Northwell Health's Feinstein Institute for Medical Research has entered a strategic alliance with GE Ventures to support the institute’s Center for Bioelectronic Medicine (CBEM). Thu, 23 Feb 2017 00:00:00 GMT US FDA accepts regulatory submission for Pfizer’s inotuzumab ozogamicin http://www.pharmaceutical-technology.com/news/newsus-fda-accepts-regulatory-submission-for-pfizers-inotuzumab-ozogamicin-5746156 http://www.pharmaceutical-technology.com/news/newsus-fda-accepts-regulatory-submission-for-pfizers-inotuzumab-ozogamicin-5746156 US-based pharmaceutical company Pfizer’s biologics licence application (BLA) for inotuzumab ozogamicin has been accepted for filing and granted priority review by the US Food and Drug Administration (FDA). Thu, 23 Feb 2017 00:00:00 GMT A Combined Approach to Deliver Serialisation Solutions http://www.pharmaceutical-technology.com/downloads/whitepapers/process_automation/combined-approach-sterilisation-solutions/ http://www.pharmaceutical-technology.com/downloads/whitepapers/process_automation/combined-approach-sterilisation-solutions/ SEA Vision and Zenith Technologies have formed a global partnership to support pharmaceutical companies with the impending challenge of installing and integrating serialisation across drug manufacturing sites. Wed, 22 Feb 2017 11:20:00 GMT Real-World Revolution - Unlock Valuable Insights Throughout the Lifecycle http://www.pharmaceutical-technology.com/downloads/whitepapers/consultancy/trends-in-real-world-evidence/ http://www.pharmaceutical-technology.com/downloads/whitepapers/consultancy/trends-in-real-world-evidence/ Pharma is undergoing an 'evidence revolution' as real-world evidence breaks out from the confines of market access and infiltrates every part of the life of a medicine, from discovery through to late-stage commercial. Wed, 22 Feb 2017 09:53:00 GMT Neovacs and BioSense partner to develop and commercialise IFNa Kinoid in China http://www.pharmaceutical-technology.com/news/newsneovacs-and-biosense-sign-agreement-for-development-and-commercialisation-of-ifn-kinoid-in-china-5746084 http://www.pharmaceutical-technology.com/news/newsneovacs-and-biosense-sign-agreement-for-development-and-commercialisation-of-ifn-kinoid-in-china-5746084 French-based Neovacs has signed a commercial licence option agreement with BioSense Global for the development and commercial rights of IFNα Kinoid vaccine to treat lupus and dermatomyositis in China. Wed, 22 Feb 2017 00:00:00 GMT AstraZeneca and TerSera sign agreement to commercialise Zoladex in US and Canada http://www.pharmaceutical-technology.com/news/newsastrazeneca-and-tersera-sign-agreement-to-commercialise-zoladex-in-us-and-canada-5745187 http://www.pharmaceutical-technology.com/news/newsastrazeneca-and-tersera-sign-agreement-to-commercialise-zoladex-in-us-and-canada-5745187 UK-based AstraZeneca has entered an agreement to sell the commercial rights for Zoladex (goserelin acetate implant) in the US and Canadian markets to pharmaceutical company TerSera Therapeutics. Wed, 22 Feb 2017 00:00:00 GMT